National Psoriasis Foundation

Drug Pipeline

« Back to the pipeline

Company

Janssen

Description

Simponi Aria is the infusion form of Simponi, which is currently approved for psoriatic arthritis as an injectable medication. Janssen has submitted an application to the FDA to approve Simponi Aria infusion for psoriatic arthritis.

Therapeutic Approach

Injectables

Indication

Psoriatic Arthritis

Mechanism

Anti-inflammatory (TNF-alpha inhibitor)

Phase

To patients

Get the latest research news and tips on managing your psoriasis and psoriatic arthritis.